The Latest in BioMedInnovations News


Chief Executive Officer

BioMedInnovations LLC

I’m excited to be guiding the efforts of BioMedInnovations. BMI is developing a novel perfusion device to 1) preserve donated organ quality and 2) provide metrics for the transplant community to effectively determine organ health. Using a programmable physio-mimetic waveform (PPW) we are able to more consistently and effectively perfuse organs to the capillary bed. We are committed to significantly reducing the number of deaths of patients waiting on organ transplant lists.


BioMedInnovations LLC welcomes Sherif Gabriel as Chief Executive Officer at BioMedInnovations LLC.

CaVESWave® is an investigative device in the preclinical stage of development. It has not yet been tested extensively on humans or approved for commercial sale by the FDA or by any other regulatory body. ©BMI Proprietary and Confidential